-+ 0.00%
-+ 0.00%
-+ 0.00%

Aura Biosciences prices USD 260.3 million follow-on stock, pre-funded warrants at USD 6

PUBT·05/04/2026 13:05:22
Listen to the news
Aura Biosciences prices USD 260.3 million follow-on stock, pre-funded warrants at USD 6
  • Aura Biosciences priced an underwritten public offering of 39,591,000 common shares at USD 6 per share, raising expected gross proceeds of about USD 260.3 million.
  • Deal also includes pre-funded warrants for up to 3,800,000 shares priced at USD 5.99999, with a USD 0.00001 exercise price.
  • Underwriters received a 30-day option to buy up to 6,508,650 additional shares.
  • Net proceeds earmarked for clinical development and registration-enabling work for bel-sar, with remaining net proceeds slated to repurchase up to 6,922,870 shares from Matrix Capital Management Master Fund at USD 5.64 per share.
  • Offering expected to close on or about May 5, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aura Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605040903PRIMZONEFULLFEED9712304) on May 04, 2026, and is solely responsible for the information contained therein.